Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy
- 31 March 2011
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 10 (5), 267-275
- https://doi.org/10.1016/j.autrev.2010.09.015
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin SyndromeScience Translational Medicine, 2010
- Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosisProceedings of the National Academy of Sciences of the United States of America, 2010
- Electrophilic Peroxisome Proliferator–Activated Receptor-γ Ligands Have Potent Antifibrotic Effects in Human Lung FibroblastsAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Hypoxia-induced alveolar epithelial-mesenchymal transition requires mitochondrial ROS and hypoxia-inducible factor 1American Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Hair Follicle Stem Cell-Specific PPARγ Deletion Causes Scarring AlopeciaJournal of Investigative Dermatology, 2009
- Peroxisome proliferator‐activated receptor‐γ abrogates Smad‐dependent collagen stimulation by targeting the p300 transcriptional coactivatorThe FASEB Journal, 2009
- WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosisJCI Insight, 2009
- Systemic sclerosis: a prototypic multisystem fibrotic disorderJCI Insight, 2007
- Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: A time course studyProstaglandins, Leukotrienes & Essential Fatty Acids, 2007
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004